It has been reported that TXNIP is an important mediator for NLRP3 inflammasome activation, emerged as a target in multiple diseases, including cervical inflammation, diabetic nephropathy, and tubular injury [24–26]. Here, NLRP3 is linked to diabetic kidney disease.